<DOC>
	<DOCNO>NCT02471040</DOCNO>
	<brief_summary>This study design examine value infuse BHB type 1 diabetic subject experimentally induced hypoglycemic episode conjunction test cognitive function . This lay basis subsequent trial explore novel use therapeutic dos oral ketone formulation currently commercial development , could serve adjunct therapy protect brain hypoglycemia type 1 diabetic subject experience recurrent hypoglycemia .</brief_summary>
	<brief_title>Brain Ketone Metabolism Type 1 Diabetes</brief_title>
	<detailed_description>Healthy control well type 1 diabetic subject undergo hyperinsulinemic-hypoglycemic clamp concomitant BHB saline ( control ) infusion random order . During experimental condition participant complete battery validate cognitive test sensitive cognitive impairment typically cause hypoglycemia .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<criteria>1 . Type 1 diabetes mellitus &gt; 5 year ( Cpeptide negative , age 1860 year , intensive insulin therapy ( HbA1c &lt; 7.5 % ) 2 . Nondiabetic volunteer , age 1865 year meet exclusion criterion . 1 . Pregnancy 2 . Significant baseline anemia ( hemoglobin &lt; 11.0 hematocrit &lt; 33 % ) 3 . A history liver cirrhosis portocaval shunt surgery . 4 . Any contraindication MRI scan . 5 . Subjects follow vegetarian diet 6 . Subjects exercise heavily regular basis ( i.e . marathon runner , body builder form excessive exercise determine PI ) 7 . Subjects history anxiety/ panic attack</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>brain metabolism</keyword>
	<keyword>cognitive function</keyword>
</DOC>